A recent study performed by our group using talin-1 demonstrated that low expression of talin-1 on both mRNA and protein levels was significantly associated with advanced pathological features and worse disease-specific survival (DSS) in patients with colorectal cancer (CRC) (14). The gene discussed is TLN1; the disease is colorectal carcinoma.